Matches in SemOpenAlex for { <https://semopenalex.org/work/W2015953253> ?p ?o ?g. }
- W2015953253 endingPage "1921" @default.
- W2015953253 startingPage "1917" @default.
- W2015953253 abstract "To evaluate the reliability of medical history taken before hormonal medication administration to identify women with an increased risk for thromboembolic events detected by laboratory screening.Prospective study.Outpatient endocrine clinic of a university-based hospital.Four hundred forty-three consecutive women (median age 49 years) who presented with endocrine disorders.None.Parallel screening, on first visit, with a complete medical history, and same-day laboratory screening for thromboembolic risk. Laboratory examination in a two-step procedure with a standard assay and confirmation by genotyping on the second visit.A total of 13.8% (61/443) patients with an abnormal activated protein C (APC) resistance test were identified. Second blood samples revealed a prevalence of factor V (Leiden) heterozygosity in 10.9% (homozygosity in 0.2%). There was a significantly higher prevalence of thrombotic events in a first degree relative of patients with APC resistance (in 18.3%) compared with women with a normal test outcome (in 7.8%). However, medical history (personal and family history) was negative concerning hints for thromboembolic events in more than 80% of patients with a laboratory risk profile for thromboembolic morbidity. No association of APC and factor V testing with the patients' gynecological/obstetric history (e.g., live birth rate, miscarriages) was observed.Medical history alone may be inadequate to identify all patients at risk for thromboembolic complications with hormonal treatment." @default.
- W2015953253 created "2016-06-24" @default.
- W2015953253 creator A5000702508 @default.
- W2015953253 creator A5060395994 @default.
- W2015953253 creator A5082885736 @default.
- W2015953253 creator A5087168324 @default.
- W2015953253 date "2011-05-01" @default.
- W2015953253 modified "2023-09-25" @default.
- W2015953253 title "Medical history screening for thrombophilic risk: is this adequate?" @default.
- W2015953253 cites W1516067462 @default.
- W2015953253 cites W1896959165 @default.
- W2015953253 cites W19183810 @default.
- W2015953253 cites W1956420173 @default.
- W2015953253 cites W1956836344 @default.
- W2015953253 cites W1964867773 @default.
- W2015953253 cites W1965958910 @default.
- W2015953253 cites W1966451334 @default.
- W2015953253 cites W1972058538 @default.
- W2015953253 cites W1973656883 @default.
- W2015953253 cites W1974963658 @default.
- W2015953253 cites W1977443078 @default.
- W2015953253 cites W1986999852 @default.
- W2015953253 cites W1992865679 @default.
- W2015953253 cites W1997277648 @default.
- W2015953253 cites W1999668990 @default.
- W2015953253 cites W2003196466 @default.
- W2015953253 cites W2007875677 @default.
- W2015953253 cites W2008660261 @default.
- W2015953253 cites W2011220565 @default.
- W2015953253 cites W2015756948 @default.
- W2015953253 cites W2018051354 @default.
- W2015953253 cites W2021415518 @default.
- W2015953253 cites W2025189781 @default.
- W2015953253 cites W2027492515 @default.
- W2015953253 cites W2037079095 @default.
- W2015953253 cites W2042685395 @default.
- W2015953253 cites W2051849262 @default.
- W2015953253 cites W2053432596 @default.
- W2015953253 cites W2053774698 @default.
- W2015953253 cites W2055816125 @default.
- W2015953253 cites W2058683934 @default.
- W2015953253 cites W2059308063 @default.
- W2015953253 cites W2059461980 @default.
- W2015953253 cites W2064736463 @default.
- W2015953253 cites W2069343109 @default.
- W2015953253 cites W2079050804 @default.
- W2015953253 cites W2088995218 @default.
- W2015953253 cites W2094669357 @default.
- W2015953253 cites W2104059005 @default.
- W2015953253 cites W2104062454 @default.
- W2015953253 cites W2105515856 @default.
- W2015953253 cites W2107766028 @default.
- W2015953253 cites W2109654476 @default.
- W2015953253 cites W2117767595 @default.
- W2015953253 cites W2131992106 @default.
- W2015953253 cites W2136152362 @default.
- W2015953253 cites W2141317767 @default.
- W2015953253 cites W2144238512 @default.
- W2015953253 cites W2148746651 @default.
- W2015953253 cites W2151233465 @default.
- W2015953253 cites W2152646926 @default.
- W2015953253 cites W2155668548 @default.
- W2015953253 cites W2158144878 @default.
- W2015953253 cites W2163333618 @default.
- W2015953253 cites W2278967921 @default.
- W2015953253 cites W2283442999 @default.
- W2015953253 cites W2318577668 @default.
- W2015953253 cites W2328547014 @default.
- W2015953253 cites W2338765002 @default.
- W2015953253 cites W2398170993 @default.
- W2015953253 cites W2400794170 @default.
- W2015953253 cites W4293857995 @default.
- W2015953253 cites W4366766260 @default.
- W2015953253 doi "https://doi.org/10.1016/j.fertnstert.2011.02.053" @default.
- W2015953253 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21444074" @default.
- W2015953253 hasPublicationYear "2011" @default.
- W2015953253 type Work @default.
- W2015953253 sameAs 2015953253 @default.
- W2015953253 citedByCount "2" @default.
- W2015953253 countsByYear W20159532532013 @default.
- W2015953253 countsByYear W20159532532014 @default.
- W2015953253 crossrefType "journal-article" @default.
- W2015953253 hasAuthorship W2015953253A5000702508 @default.
- W2015953253 hasAuthorship W2015953253A5060395994 @default.
- W2015953253 hasAuthorship W2015953253A5082885736 @default.
- W2015953253 hasAuthorship W2015953253A5087168324 @default.
- W2015953253 hasBestOaLocation W20159532531 @default.
- W2015953253 hasConcept C104317684 @default.
- W2015953253 hasConcept C126322002 @default.
- W2015953253 hasConcept C131872663 @default.
- W2015953253 hasConcept C135763542 @default.
- W2015953253 hasConcept C185592680 @default.
- W2015953253 hasConcept C187212893 @default.
- W2015953253 hasConcept C206179267 @default.
- W2015953253 hasConcept C2780842393 @default.
- W2015953253 hasConcept C2780868729 @default.
- W2015953253 hasConcept C2781179581 @default.
- W2015953253 hasConcept C29456083 @default.